Home Back to the drawing board: Redefining statistical significance

Back to the drawing board: Redefining statistical significance

Christian K Schneider | Head of Biopharma Excellence

A recent panel debate moderated by Christian K. Schneider, head of Biopharma Excellence, explored emerging approaches to clinical research and data collection for therapies linked to rare diseases.

Go Back

Start a conversation today

Socials:

First Name*

Last Name*

Telephone

Country

Company Name*

Email*

Your message

Please tick this box to agree to our Privacy Policy.*

Please tick this box if you agree to periodic updates from Biopharma Excellence. If you do not wish to receive any communication from us, you may unsubscribe at any time.